News-Morimatsu LifeSciences

FROM CRITICAL EQUIPMENT TO
TOTAL PROCESS SOLUTION

BACK

Invitation Letter | Pharmadule Morimatsu Invites You to Join Us at 32nd Annual ISPE-CaSA Tech Show

We are glad to share that we will be attending 32nd Annual ISPE-CaSA Tech Show!📍 Raleigh Convention Center📅 February 25, 2025📍 Booth: 842We will exhibit and present our integrated modular solutions for process systems and facilities. We'd like to share and discuss our latest projects achie
Invitation Letter | Pharmadule Morimatsu Invites You to Join Us at Biologics Festival

We are glad to share that we will be attending Biologics Festival!📍 Crown Promenade Melbourne,Australia📅 February 4-5, 2025📍 Booth: 2We will exhibit and present our integrated modular solutions for process systems and facilities. We'd like to share and discuss our latest projects achieveme
Invitation Letter | Pharmadule Morimatsu Invites You to Join Us at ISPE Facilities of the Future Conference

We are glad to share that we will be attending ISPE Facilities of the Future Conference!📍 San Francisco, CA USA📅 January 27-28, 2025📍 Booth: 205We will exhibit and present our integrated modular solutions for process systems and facilities. We'd like to share and discuss our latest project
Morimatsu's Exosome Manufacturing Process Solutions: Facilitating Large-scale and High-quality Exosome Production

All cells, whether prokaryotic or eukaryotic, release extracellular vesicles (EVs) during normal physiological activities and pathological changes. These EVs are mainly classified into two categories: ectosomes and exosomes.Exosomesare nano-sized lipid structures with a diameter ranging from 3
Exhibition Review | Morimatsu's Debut at CPHI Middle East: Unlocking New Opportunities for the Pharmaceutical Industry

From December 10 to 12, the CPHI Middle East 2024 was held at the Riyadh International Convention and Exhibition Center in Saudi Arabia.As the most comprehensive pharmaceutical event in the Middle East and Africa region, it attracted industry leaders, innovators and decision makers from more than 10

Prev 1 2 3 4 5··· Next